The AJMC® Atopic Dermatitis compendium is a comprehensive resource for clinical news and expert insights for the chronic skin condition that typically develops in early childhood.
July 1st 2025
This new study identifies key contributors to mental health decline in individuals with atopic dermatitis, highlighting the need for integrated care.
Develop a deeper understanding of the atopic dermatitis (AD) patient journey, explore topical therapies and treatment sequencing advancements, and gain insight regarding the payer’s perspective on AD therapies.
AD Progression Adversely Influenced by Outdoor Air Pollution
Topical Calcineurin Inhibitors for AD Not Associated With Cancer
Dupilumab Efficacy in AD Not Affected by Age of Disease Onset
Skin Biomarkers Found to Predict Development of Pediatric Atopic Dermatitis